BIO-key International is trading 10.18% down at $3.04; no clear company-specific announcement explaining the October 26 decline was identified.
- The latest company news found was an October 22 Middle East government contract announcement, which does not establish a cause for the drop.
- The S&P 500, Nasdaq Composite, and Dow Jones are all higher, so available evidence does not point to a broad-market decline driving the move.